• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期检测生物学定义的阿尔茨海默病时,下后扣带回中N-乙酰天门冬氨酸与肌酸水平的研究

Lower Posterior Cingulate N-Acetylaspartate to Creatine Level in Early Detection of Biologically Defined Alzheimer's Disease.

作者信息

Chen Qianyun, Abrigo Jill, Liu Wanting, Han Elyia Yixun, Yeung David Ka Wai, Shi Lin, Au Lisa Wing Chi, Deng Min, Chen Sirong, Leung Eric Yim Lung, Ho Chi Lai, Mok Vincent Chung Tong, Chu Winnie Chiu Wing

机构信息

Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.

Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.

出版信息

Brain Sci. 2022 May 31;12(6):722. doi: 10.3390/brainsci12060722.

DOI:10.3390/brainsci12060722
PMID:35741606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9220959/
Abstract

Alzheimer’s disease (AD) was recently defined as a biological construct to reflect neuropathologic status, and both abnormal amyloid and tau are required for a diagnosis of AD. We aimed to determine the proton MR spectroscopic (1H-MRS) patterns of the posterior cingulate in biologically defined AD. A total of 68 participants were included in this study, comprising 37 controls, 16 early AD, and 15 late AD, who were classified according to their amyloid and tau status and presence of hippocampal atrophy. Compared with controls, early AD showed lower N-acetylaspartate (NAA)/creatine (Cr) (p = 0.003), whereas late AD showed lower NAA/Cr and higher myoInositol (mI)/Cr (all with p < 0.05). Lower NAA/Cr correlated with a greater global amyloid load (r = −0.47, p < 0.001) and tau load (r = −0.51, p < 0.001) and allowed a discrimination of early AD from controls (p < 0.001). Subgroup analysis showed that NAA/Cr also allowed a differentiation of early AD from controls in the cognitively unimpaired subjects, with an area under the receiver operating characteristics curve, sensitivity, and specificity of 0.96, 100%, and 83.8%, respectively. Lower posterior cingulate NAA levels may help to inform underlying neuropathologic changes in the early stage of AD.

摘要

阿尔茨海默病(AD)最近被定义为一种反映神经病理状态的生物学概念,AD的诊断需要同时存在异常的淀粉样蛋白和tau蛋白。我们旨在确定生物学定义的AD患者扣带回后部的质子磁共振波谱(1H-MRS)模式。本研究共纳入68名参与者,包括37名对照者、16名早期AD患者和15名晚期AD患者,他们根据淀粉样蛋白和tau蛋白状态以及海马萎缩情况进行分类。与对照者相比,早期AD患者的N-乙酰天门冬氨酸(NAA)/肌酸(Cr)较低(p = 0.003),而晚期AD患者的NAA/Cr较低,肌醇(mI)/Cr较高(均p < 0.05)。较低的NAA/Cr与更高的整体淀粉样蛋白负荷(r = -0.47,p < 0.001)和tau蛋白负荷(r = -0.51,p < 0.001)相关,并且能够区分早期AD与对照者(p < 0.001)。亚组分析表明,NAA/Cr也能够在认知未受损的受试者中区分早期AD与对照者,受试者工作特征曲线下面积、敏感性和特异性分别为0.96、100%和83.8%。扣带回后部较低的NAA水平可能有助于了解AD早期潜在的神经病理变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/0c2a3292d093/brainsci-12-00722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/6aee59226898/brainsci-12-00722-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/c1473bb54c69/brainsci-12-00722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/0c2a3292d093/brainsci-12-00722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/6aee59226898/brainsci-12-00722-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/c1473bb54c69/brainsci-12-00722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a3f/9220959/0c2a3292d093/brainsci-12-00722-g003.jpg

相似文献

1
Lower Posterior Cingulate N-Acetylaspartate to Creatine Level in Early Detection of Biologically Defined Alzheimer's Disease.早期检测生物学定义的阿尔茨海默病时,下后扣带回中N-乙酰天门冬氨酸与肌酸水平的研究
Brain Sci. 2022 May 31;12(6):722. doi: 10.3390/brainsci12060722.
2
Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.通过质子磁共振波谱检测早期阿尔茨海默病神经病理学
J Neurosci. 2014 Dec 3;34(49):16247-55. doi: 10.1523/JNEUROSCI.2027-14.2014.
3
Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.阿尔茨海默病的 1H-MR 光谱和脑脊液生物标志物的相关性:三个不同脑区的不同行为。
J Alzheimers Dis. 2013;36(1):155-63. doi: 10.3233/JAD-120778.
4
Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease.阿尔茨海默病患者海马体积与后扣带回及海马质子磁共振波谱的相关性
Dement Neuropsychol. 2010 Apr-Jun;4(2):109-113. doi: 10.1590/S1980-57642010DN40200006.
5
An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.1H-MRS 框架可预测 PSEN1 基因突变携带者阿尔茨海默病症状的发作。
Alzheimers Dement. 2014 Sep;10(5):552-61. doi: 10.1016/j.jalz.2013.08.282. Epub 2013 Nov 13.
6
Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.采用3特斯拉磁共振波谱检测轻度认知障碍和阿尔茨海默病患者海马体和后扣带回区域的代谢变化。
Acta Radiol. 2009 Apr;50(3):312-9. doi: 10.1080/02841850802709219.
7
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.轻度认知障碍和阿尔茨海默病的区域代谢模式:一项氢质子磁共振波谱研究
Neurology. 2000 Jul 25;55(2):210-7. doi: 10.1212/wnl.55.2.210.
8
Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.利用质子磁共振波谱分析来识别轻度认知障碍。
Int Psychogeriatr. 2012 Jan;24(1):19-27. doi: 10.1017/S1041610211000962. Epub 2011 Jun 16.
9
[Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].[阿尔茨海默病患者扣带回后部的氢质子磁共振波谱分析:一项病例对照研究]
Zhonghua Yi Xue Za Zhi. 2009 Jan 6;89(1):37-40.
10
An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease.一项关于美金刚的开放标签探索性研究:轻度至中度阿尔茨海默病患者质子磁共振波谱与认知的相关性
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):312-20. doi: 10.1159/000341604. Epub 2012 Aug 16.

引用本文的文献

1
Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer's Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE Genotype.使用阿尔茨海默病生物体液、PET、尸检病理学生物标志物和 APOE 基因型了解质子磁共振波谱神经化学变化。
Int J Mol Sci. 2024 Sep 19;25(18):10064. doi: 10.3390/ijms251810064.
2
Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy.多模态研究轻度认知障碍和老年期抑郁症的神经病理学和神经代谢物,使用 C-PiB β-淀粉样蛋白 PET 和 7T 磁共振波谱。
Neurobiol Aging. 2024 Oct;142:27-40. doi: 10.1016/j.neurobiolaging.2024.06.003. Epub 2024 Jun 20.
3

本文引用的文献

1
Alzheimer's disease.阿尔茨海默病。
Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2.
2
Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and H-MRS Brain Metabolites in Alzheimer's Disease: A Systematic Review.阿尔茨海默病患者的脑脊液淀粉样蛋白β、tau 水平、载脂蛋白和 H-MRS 脑代谢物:系统评价。
Acad Radiol. 2021 Oct;28(10):1447-1463. doi: 10.1016/j.acra.2020.06.006. Epub 2020 Jul 7.
3
Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.
Brain metabolites are associated with sleep architecture and cognitive functioning in older adults.
脑代谢物与老年人的睡眠结构和认知功能相关。
Brain Commun. 2024 Jul 19;6(4):fcae245. doi: 10.1093/braincomms/fcae245. eCollection 2024.
4
Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review.磁共振波谱在神经退行性疾病诊断中的应用:一项系统综述。
Heliyon. 2024 Apr 30;10(9):e30521. doi: 10.1016/j.heliyon.2024.e30521. eCollection 2024 May 15.
5
Obstructive sleep apnea and attention deficits: A systematic review of magnetic resonance imaging biomarkers and neuropsychological assessments.阻塞性睡眠呼吸暂停与注意力缺陷:磁共振成像生物标志物和神经心理学评估的系统综述。
Brain Behav. 2023 Nov;13(11):e3262. doi: 10.1002/brb3.3262. Epub 2023 Sep 24.
6
APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM Polluted Cities.载脂蛋白 E 外周和大脑影响:载脂蛋白 E4 携带者加速其阿尔茨海默病连续体,并在 PM 污染城市有高自杀风险。
Biomolecules. 2023 May 31;13(6):927. doi: 10.3390/biom13060927.
7
Exploration of RCBF and Metabolic Changes in the Brain Functional Areas of Patients with Hypothyroidism by ASL and MRS Techniques.应用 ASL 和 MRS 技术探讨甲状腺功能减退症患者脑功能区局部脑血流量和代谢变化。
Dis Markers. 2022 Oct 14;2022:9204119. doi: 10.1155/2022/9204119. eCollection 2022.
8
Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues.能量危机与阿尔茨海默病自噬和铁死亡的关系:当前证据和未来方向。
Curr Neuropharmacol. 2023;21(1):67-86. doi: 10.2174/1570159X20666220817140737.
轻度认知障碍和阿尔茨海默病患者的海马谷氨酸和后扣带回 N-乙酰天冬氨酸减少与情景记忆表现和扣带白质完整性相关:一项初步研究。
J Alzheimers Dis. 2020;73(4):1385-1405. doi: 10.3233/JAD-190773.
4
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain H-MRS and volumetric changes: A two- year retrospective follow-up study.使用脑 H-MRS 和容积变化预测轻度认知障碍向阿尔茨海默病的转化:一项为期两年的回顾性随访研究。
Neuroimage Clin. 2019;23:101843. doi: 10.1016/j.nicl.2019.101843. Epub 2019 Apr 30.
5
Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.脑肌醇作为淀粉样相关病理学的潜在标志物:一项纵向研究。
Neurology. 2019 Jan 29;92(5):e395-e405. doi: 10.1212/WNL.0000000000006852. Epub 2019 Jan 4.
6
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.阿尔茨海默病的基于血液的生物标志物:为走向临床铺平道路。
Nat Rev Neurol. 2018 Nov;14(11):639-652. doi: 10.1038/s41582-018-0079-7.
7
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
8
Longitudinal tau PET in ageing and Alzheimer's disease.tau 蛋白 PET 成像在衰老和阿尔茨海默病中的应用
Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.
9
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.磁共振波谱显示后扣带回皮质 N-乙酰天门冬氨酸/肌醇比值降低可能是临床前阿尔茨海默病的风险标志物之一:一项 7 年随访研究。
J Alzheimers Dis. 2017;60(4):1411-1427. doi: 10.3233/JAD-170450.
10
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.肌醇变化先于淀粉样蛋白病理改变,且与阿尔茨海默病中的APOE基因型相关。
Neurology. 2016 May 10;86(19):1754-61. doi: 10.1212/WNL.0000000000002672. Epub 2016 Apr 15.